The pharmaceutical world is witnessing an exciting evolution in how we tackle autoimmune and inflammatory conditions, and OX40 ligand inhibitors are leading this charge. This innovative class of therapeutics represents a smarter, more refined way to manage diseases where the immune system mistakenly attacks healthy tissue. Instead of using a sledgehammer approach that suppresses the entire...